More reported feverishness, chills, fatigue, headache, joint pain, malaise, muscle ache after heterologous versus homogenous doses
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID’d
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
Guidance Issued for Managing CVST After COVID-19 Vaccination
CVST with thrombocytopenia reported after COVID-19 vaccine with adenoviral vector; management similar to heparin-induced thrombocytopenia
12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.
Time from vaccination to symptom onset varied from six to 15 days; initial presentation was headache in 11 cases
No Signal of Facial Paralysis Found for mRNA COVID-19 Vaccines
No signal of disproportionality of facial paralysis seen for broad or narrow definitions versus other viral vaccines, influenza vaccines alone
‘Possible Link’ Found Between AstraZeneca COVID-19 Vaccine, Rare Blood Clots
EU agency experts reviewed several dozen cases and determined that such clots are ‘very rare’ side effects of the vaccine
More Cases of Blood Clots Linked to AstraZeneca COVID-19 Vaccine
Britain’s medical regulatory agency has received 30 reports of clotting events after people were vaccinated
AstraZeneca Vaccine Safe and Effective, European Medicines Agency Says
Officials hope announcement will ease concerns about possible rare side effects involving blood clots
CDC Report Shows No Evidence of Unexpected Adverse Events With COVID-19 Vaccines
Findings from the first month show no unexpected adverse events, with 6,994 adverse events and >90 percent classified as nonserious
Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020
ADRs associated with hydroxychloroquine, chloroquine more than doubled in 2020 versus 2018 and 2019